These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 1889186)
1. In vitro activity of sparfloxacin (AT-4140 and CI-978), a new quinolone antimicrobial agent, against Haemophilus and gram-positive cocci. Rudrik JT; Ferrigno SR; Gee SL Diagn Microbiol Infect Dis; 1991; 14(4):355-60. PubMed ID: 1889186 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci. Rotstein C; Amsterdam D; Beam TR; Mandell LA; Gorzynski EA Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375 [TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds. Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria. Cohen MA; Huband MD; Mailloux GB; Yoder SL; Roland GE; Heifetz CL Diagn Microbiol Infect Dis; 1991; 14(5):403-15. PubMed ID: 1665775 [TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activities of sparfloxacin (CI-978; AT-4140) and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens. Simor AE; Fuller SA; Low DE Antimicrob Agents Chemother; 1990 Nov; 34(11):2283-6. PubMed ID: 2127351 [TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis. Jones RN; Ballow CH; Schentag JJ; Johnson DM; Deinhart JA Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria. Louie A; Baltch AL; Ritz WJ; Smith RP Chemotherapy; 1991; 37(4):275-82. PubMed ID: 1665123 [TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria. Eliopoulos GM; Wennersten CB; Moellering RC Diagn Microbiol Infect Dis; 1996 May; 25(1):35-41. PubMed ID: 8831043 [TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. Cooper MA; Andrews JM; Ashby JP; Matthews RS; Wise R J Antimicrob Chemother; 1990 Nov; 26(5):667-76. PubMed ID: 2079449 [TBL] [Abstract][Full Text] [Related]
10. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria. Sefton AM; Maskell JP; Rafay AM; Whiley A; Williams JD J Antimicrob Chemother; 1997 Jun; 39 Suppl B():57-62. PubMed ID: 9222071 [TBL] [Abstract][Full Text] [Related]
11. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria. Hoban D; Grabowski M; Koss J; Weselowski V Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates. Hoogkamp-Korstanje JA; Roelofs-Willemse J J Antimicrob Chemother; 2000 Jan; 45(1):31-9. PubMed ID: 10629010 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone. Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282 [TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of sparfloxacin (AT 4140, RP 64206--SPFX) against 275 multiresistant clinical isolates. Giamarellou H; Voutsinas D; Xirouchaki E J Chemother; 1992 Feb; 4(1):12-5. PubMed ID: 1328554 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. Visser MR; Rozenberg-Arska M; Beumer H; Hoepelman IM; Verhoef J Antimicrob Agents Chemother; 1991 May; 35(5):858-68. PubMed ID: 1854167 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of sparfloxacin compared with those of five other quinolones. Cantón E; Pemán J; Jimenez MT; Ramón MS; Gobernado M Antimicrob Agents Chemother; 1992 Mar; 36(3):558-65. PubMed ID: 1320362 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci. Shonekan D; Mildvan D; Handwerger S Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649 [TBL] [Abstract][Full Text] [Related]
18. Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria. Bassetti M; Dembry LM; Farrel PA; Callan DA; Andriole VT Diagn Microbiol Infect Dis; 2001 Nov; 41(3):143-8. PubMed ID: 11750168 [TBL] [Abstract][Full Text] [Related]
19. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990. Bauernfeind A J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398 [TBL] [Abstract][Full Text] [Related]